I agree that this site is using cookies. You can find further informations here.
X
Pilat, Mary Jo
47  results:
Search for persons X
?
1

Multicenter Phase II Trial of the PARP Inhibitor Olaparib i..:

Fanucci, Kristina ; Pilat, Mary Jo ; Shyr, Derek...
Cancer Research Communications.  3 (2023)  2 - p. 192-201 , 2023
Link: https://doi.org/10.1158/..
 
?
2

NCI 7977: A Phase I Dose-Escalation Study of Intermittent O..:

Cecchini, Michael ; Walther, Zenta ; Wei, Wei...
Cancer Research Communications.  3 (2023)  6 - p. 1113-1117 , 2023
Link: https://doi.org/10.1158/..
 
?
3

Identifying treatment options for BRAFV600 wild-type metast..:

LoRusso, Patricia M. ; Sekulic, Aleksandar ; Sosman, Jeffrey A....
PLOS ONE.  16 (2021)  4 - p. e0248097 , 2021
Link: https://doi.org/10.1371/..
 
?
4

Impact of Type of Healthcare Experience Before Physician As..:

Lolar, Sara ; Pilat, Mary Jo ; Welch, Robert D.
Journal of Allied Health.  49 (2020)  3 - p. 176-180 , 2020
Link: https://www.jstor.org/st..
 
?
5

Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) ..:

Shapiro, Geoffrey I. ; LoRusso, Patricia ; Kwak, Eunice...
Investigational New Drugs.  38 (2019)  2 - p. 419-432 , 2019
Link: https://doi.org/10.1007/..
 
?
6

A phase 2 study of vorinostat in locally advanced, recurren..:

Goncalves, Priscila H. ; Heilbrun, Lance K. ; Barrett, Michael T....
Oncotarget.  8 (2017)  20 - p. 32918-32929 , 2017
Link: https://doi.org/10.18632..
 
?
7

Lack of food effect on single-dose pharmacokinetics of briv..:

LoRusso, Patricia ; Shapiro, Geoffrey I. ; Hurwitz, Herbert...
Cancer Chemotherapy and Pharmacology.  68 (2011)  6 - p. 1377-1385 , 2011
Link: https://doi.org/10.1007/..
 
?
8

Effect of coadministration of ketoconazole, a strong CYP3A4..:

LoRusso, Patricia ; Heath, Elisabeth I. ; McGreivy, Jesse...
Investigational New Drugs.  26 (2008)  5 - p. 455-462 , 2008
Link: https://doi.org/10.1007/..
 
?
9

Vascular targeting agents:

Pilat, Mary Jo ; McCormick, Julie ; LoRusso, Patricia Mucci
Current Oncology Reports.  6 (2004)  2 - p. 103-110 , 2004
Link: https://doi.org/10.1007/..
 
?
10

NCI 7977: A Phase I Dose-Escalation Study of Intermittent O..:

Cecchini, Michael ; Walther, Zenta ; Wei, Wei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292219/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Multicenter Phase II Trial of the PARP Inhibitor Olaparib i..:

Fanucci, Kristina ; Pilat, Mary Jo ; Shyr, Derek...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035510/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Pilot Trial of Selecting Molecularly-Guided Therapy for Pat..:

LoRusso, Patricia M ; Boerner, Scott A ; Pilat, Mary Jo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560131/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
13

Identifying treatment options for BRAFV600 wild-type metast..:

Patricia M LoRusso ; Aleksandar Sekulic ; Jeffrey A Sosman...
https://doi.org/10.1371/journal.pone.0248097.  , 2021
Link: https://doi.org/10.1371/..
 
?
14

Reverse phase protein array (RPPA) analysis:

Patricia M. LoRusso (10535356) ; Aleksandar Sekulic (3192720) ; Jeffrey A. Sosman (6517850)...
https://figshare.com/articles/dataset/Reverse_phase_protein_array_RPPA_analysis_/14382121.  , 2021
Link: https://doi.org/10.1371/..
 
?
15

Selected somatic alterations:

Patricia M. LoRusso (10535356) ; Aleksandar Sekulic (3192720) ; Jeffrey A. Sosman (6517850)...
https://figshare.com/articles/dataset/Selected_somatic_alterations_/14382130.  , 2021
Link: https://doi.org/10.1371/..
 
1-15